Company Filing History:
Years Active: 2008
Title: Xao-Fa Lin: Innovator in GABAA Receptor Modulation
Introduction
Xao-Fa Lin is a notable inventor based in Palo Alto, California. He has made significant contributions to the field of pharmacology, particularly in the modulation of GABAA receptors. His work focuses on developing innovative methods to treat various psychiatric and neurological disorders.
Latest Patents
Xao-Fa Lin holds a patent for "Heterocyclic GABAA subtype selective receptor modulators." This invention relates to a method for modulating α-subtype GABAA receptors using heterocyclic compounds of a specific formula, along with their salts, solvates, and prodrugs. The invention also encompasses pharmaceutical compositions containing these compounds, aimed at treating conditions such as depression, anxiety disorders, psychiatric disorders, cognitive disorders, sleep disorders, convulsive disorders, and pain.
Career Highlights
Xao-Fa Lin is currently employed at Roche Palo Alto LLC, where he continues to advance his research and development efforts. His work has the potential to impact the treatment landscape for various mental health and neurological conditions.
Collaborations
Xao-Fa Lin collaborates with talented professionals in his field, including David Garrett Loughhead and Sanja Novakovic. These partnerships enhance the innovative capacity of his research and contribute to the development of effective therapeutic solutions.
Conclusion
Xao-Fa Lin is a prominent inventor whose work in GABAA receptor modulation holds promise for improving treatments for a range of psychiatric and neurological disorders. His contributions to the field are noteworthy and reflect his commitment to advancing medical science.